Related Experiment Video
Updated: Aug 9, 2026
08:33
An Ex vivo Culture System to Study Thyroid Development
Published on: June 6, 2014
Congenital hyperthyroidism: the fetus as a patient
Michel Polak1, Isabelle Legac, Edith Vuillard
1INSERM 0363, AP-HP, Paris Descartes University, Paris, France. michel.polak@nck.ap-hop-paris.fr
Hormone Research
|April 4, 2006
Summary
Congenital hyperthyroidism, though rare, significantly impacts fetal development. Early detection and treatment through expert ultrasound and collaborative care are crucial for managing fetal thyroid status.
Area of Science:
- Endocrinology
- Maternal-Fetal Medicine
- Neonatology
Background:
- Congenital hyperthyroidism presents challenges in fetal growth and development.
- Maternal Graves' disease can transiently affect neonates, while persistent cases link to thyrotropin receptor abnormalities.
- Limited data exists on fetal effects compared to neonatal outcomes of maternal Graves' disease.
Purpose of the Study:
- To highlight the importance of fetal thyroid scrutiny in pregnant women with Graves' disease.
- To emphasize the need for collaborative care among specialists for optimal fetal outcomes.
- To underscore the existence and necessity of aggressive treatment for fetal hyperthyroidism.
Main Methods:
- Expert ultrasonographic evaluation of the fetal thyroid.
- Multidisciplinary team approach involving obstetricians and pediatric endocrinologists.
- Monitoring and adapting maternal treatment based on fetal thyroid status.
Main Results:
- Accurate determination of fetal thyroid status is achievable.
- Successful adaptation of maternal treatment improves fetal outcomes.
- Fetal hyperthyroidism requires prompt and aggressive management.
Conclusions:
- Fetal hyperthyroidism is a significant clinical entity requiring dedicated attention.
- Early and accurate fetal thyroid assessment is paramount in pregnancies with Graves' disease.
- The fetus is a critical patient requiring specialized care and intervention.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...